UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IgE reactivity and survival probabilities in Sézary syndrome

Journal of the American Academy of Dermatology, 2015-06, Vol.72 (6), p.e177-e177

2015

Volltextzugriff (PDF)

The role of 9-O-acetylated ganglioside D3 (CD60) and α4β1 (CD49d) expression in predicting the survival of patients with Sézary syndrome

Haematologica (Roma), 2010-11, Vol.95 (11), p.1905-1912

2010

Volltextzugriff (PDF)

Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome

Cancers, 2022-06, Vol.14 (12), p.2847

2022

Volltextzugriff (PDF)

T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1

PloS one, 2018-10, Vol.13 (10), p.e0204775-e0204775

2018

Volltextzugriff (PDF)

Comprehensive analysis of PTEN status in Sézary syndrome

Blood, 2013-11, Vol.122 (20), p.3511-3520

2013

Volltextzugriff (PDF)

Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy

Cancers, 2022-07, Vol.14 (15), p.3706

2022

Volltextzugriff (PDF)

Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab

Frontiers in immunology, 2020-09, Vol.11, p.579894-579894

2020

Volltextzugriff (PDF)

Role of Neutrophil-to-Lymphocyte Ratio (NLR) in Patients with Mycosis Fungoides

Diagnostics (Basel), 2023-06, Vol.13 (11), p.1979

2023

Volltextzugriff (PDF)

CXCL13 Is Highly Produced by Sézary Cells and Enhances Their Migratory Ability via a Synergistic Mechanism Involving CCL19 and CCL21 Chemokines

Cancer research (Chicago, Ill.), 2008-09, Vol.68 (17), p.7137-7146

2008

Volltextzugriff (PDF)

Specific IgE toward Allergenic Molecules Is a New Prognostic Marker in Patients with Sézary Syndrome

International archives of allergy and immunology, 2012-02, Vol.157 (2), p.159-167

2012

Volltextzugriff (PDF)

Challenging Cutaneous T-Cell Lymphoma: What Animal Models Tell us So Far

Journal of investigative dermatology, 2022-06, Vol.142 (6), p.1533-1540

2022

Volltextzugriff (PDF)

Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma

Journal of investigative dermatology, 2020-05, Vol.140 (5), p.1045-1053.e6

2020

Volltextzugriff (PDF)

TCL1 Participates in Early Embryonic Development and Is Overexpressed in Human Seminomas

Proceedings of the National Academy of Sciences - PNAS, 2002-09, Vol.99 (18), p.11712-11717

2002

Volltextzugriff (PDF)

Deregulated Expression of TCL1 Causes T Cell Leukemia in Mice

Proceedings of the National Academy of Sciences - PNAS, 1998-03, Vol.95 (7), p.3885-3889

1998

Volltextzugriff (PDF)

Protein kinase Akt2/PKBβ is involved in blastomere proliferation of preimplantation mouse embryos

Journal of cellular physiology, 2020-04, Vol.235 (4), p.3393-3401

2020

Volltextzugriff (PDF)

Sézary Syndrome, recent biomarkers and new drugs

Chinese Clinical Oncology, 2019-02, Vol.8 (1), p.2-2

2019

Volltextzugriff (PDF)

Genetically Driven CD39 Expression Affects Sezary Cell Viability and IL-2 Production and Detects Two Patient Subsets with Distinct Prognosis

Journal of investigative dermatology, 2022-11, Vol.142 (11), p.3009-3019.e9

2022

Volltextzugriff (PDF)

Loss of β-arrestin-2 gene and possible functional consequences on Sezary Syndrome

Cell cycle (Georgetown, Tex.), 2019-06, Vol.18 (11), p.1292-1294

2019

Volltextzugriff (PDF)

Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance

Leukemia, 2019-05, Vol.33 (5), p.1231-1242

2019

Volltextzugriff (PDF)

Continuous low‐dose gemcitabine in primary cutaneous T cell lymphoma: A retrospective study

Dermatologic therapy, 2022-06, Vol.35 (6), p.e15482-n/a

2022

Volltextzugriff (PDF)

Abstract 3912: The PI3K/mTOR dual inhibitor PF-04691502 shows antitumor activity in Sezary cells and in a xenograft mouse model

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3912-3912

2019

Volltextzugriff (PDF)

Acquired Chromosome 11q Deletion Involving the Ataxia Teleangiectasia Locus in B-Cell Non-Hodgkin’s Lymphoma: Correlation With Clinicobiologic Features

Journal of clinical oncology, 2000-07, Vol.18 (13), p.2607-2614

2000

Volltextzugriff (PDF)

Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome

Cell death & disease, 2018-12, Vol.9 (12), p.1178-15, Article 1178

2018

Volltextzugriff (PDF)

Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV

Blood, 2006-02, Vol.107 (3), p.1108-1115

2006

Volltextzugriff (PDF)

Abstract 761: The role of PI3 kinase pathway in the the skin of Sezary syndrome

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.761-761

2018

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(65)

Sprache

Englisch
(65)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(34)
Humans
(27)
Female
(15)
Biological And Medical Sciences
(14)
Oncology
(14)
Male
(12)
Medical Sciences
(11)
Middle Aged
(10)
Animals
(9)
Hematologic And Hematopoietic Diseases
(9)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(9)
Aged
(8)
Base Sequence
(8)
Dermatology
(8)
Leukemia
(8)
Lymphoma
(8)
Mice
(8)
Dna-Binding Proteins - Genetics
(7)
Gene Expression
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IgE reactivity and survival probabilities in Sézary syndrome

The role of 9-O-acetylated ganglioside D3 (CD60) and α4β1 (CD49d) expression in predicting the survival of patients with Sézary syndrome

Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome

T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1

Comprehensive analysis of PTEN status in Sézary syndrome

Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy

Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab

Role of Neutrophil-to-Lymphocyte Ratio (NLR) in Patients with Mycosis Fungoides

CXCL13 Is Highly Produced by Sézary Cells and Enhances Their Migratory Ability via a Synergistic Mechanism Involving CCL19 and CCL21 Chemokines

Specific IgE toward Allergenic Molecules Is a New Prognostic Marker in Patients with Sézary Syndrome

Challenging Cutaneous T-Cell Lymphoma: What Animal Models Tell us So Far

Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma

TCL1 Participates in Early Embryonic Development and Is Overexpressed in Human Seminomas

Deregulated Expression of TCL1 Causes T Cell Leukemia in Mice

Protein kinase Akt2/PKBβ is involved in blastomere proliferation of preimplantation mouse embryos

Sézary Syndrome, recent biomarkers and new drugs

Genetically Driven CD39 Expression Affects Sezary Cell Viability and IL-2 Production and Detects Two Patient Subsets with Distinct Prognosis

Loss of β-arrestin-2 gene and possible functional consequences on Sezary Syndrome

Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance

Continuous low‐dose gemcitabine in primary cutaneous T cell lymphoma: A retrospective study

Abstract 3912: The PI3K/mTOR dual inhibitor PF-04691502 shows antitumor activity in Sezary cells and in a xenograft mouse model

Acquired Chromosome 11q Deletion Involving the Ataxia Teleangiectasia Locus in B-Cell Non-Hodgkin’s Lymphoma: Correlation With Clinicobiologic Features

Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome

Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV

Abstract 761: The role of PI3 kinase pathway in the the skin of Sezary syndrome

Suchergebnisse filtern